Searched for
RAMPRASAD REDDY
Aurobindo Pharma, promoters settle insider trading case with SebiSebi had done an investigation into the trading in the scrip of Aurobindo Pharma during the period from July 22, 2008 to March 20, 200914 May, 2020, 08.29 PM IST- Edelweiss Securities maintains ‘hold’ on Aurobindo Pharma, target price Rs 535The brokerage believes earnings growth beyond FY21 would remain challenging given limited growth drivers and doubling of R&D.11 Feb, 2020, 08.28 AM IST
- Sebi imposes Rs 23 cr fine on Aurobindo Pharma, promoters and related entitiesThe probe found that the promoter entities traded in the scrip of APL based on unpublished price sensitive information.23 Sep, 2019, 09.22 PM IST
- Aurobindo Pharma says co, subsidiary made party to litigation proceeding in USThe drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless alle...07 Jun, 2019, 02.25 PM IST
- How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma companyRamprasad Reddy has his skin the game; he has made some timely bets with a nifty strategy for Aurobindo.13 Sep, 2018, 06.38 PM IST
- Buy Aurobindo Pharma, target Rs 630: Dr CK NarayanBuy Aurobindo Pharma Ltd. at a price target of Rs 630.0 and a stop loss at Rs 610 from the entry point.12 Apr, 2018, 09.08 AM IST
- Sell Aurobindo Pharma, target Rs 568: Dr CK NarayanSell Aurobindo Pharma Ltd. at a price target of Rs 568.0 and a stop loss at Rs 585 from entry point.15 Mar, 2018, 12.05 PM IST
- Buy Aurobindo Pharma, target Rs 610: Manas JaiswalBuy Aurobindo Pharma Ltd. at a price target of Rs 610.0 and a stop loss at Rs 574 from entry point.23 Feb, 2018, 08.42 AM IST
- Buy Aurobindo Pharma, target Rs 722: Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 722.0 and a stoploss at Rs 668 from entry point.12 Dec, 2017, 08.37 AM IST
- Buy Aurobindo Pharma, target Rs 850: Kunal BothraBuy Aurobindo Pharma at a price target of Rs 850 and a stop loss at Rs 750 from the entry point.06 Nov, 2017, 08.43 AM IST
- Buy Aurobindo Pharma, target Rs 785: Shrikant ChouhanBuy Aurobindo Pharma at a price target of Rs 785 and a stop loss at Rs 732 from entry point.13 Oct, 2017, 07.53 AM IST
- Aurobindo Pharma reports Q3 net loss of Rs 28.54 crAurobindo Pharma posted a consolidated net loss of Rs 28.54 crore for Q3, primarily on account of foreign exchange losses suffered during t...13 Feb, 2012, 09.32 PM IST
- Aurobindo Pharma posts Rs 80.16 cr loss in Q2Aurobindo Pharma today posted a consolidated net loss of Rs 80.16 crore for the second quarter ended September 30, 2011.08 Nov, 2011, 08.36 PM IST
- Aurobindo Pharma FY'11 net up marginally at Rs 563.45 crDrug firm Aurobindo Pharma today said its consolidated net profit rose marginally to Rs 563.45 crore for the year ended March 31, 2011.09 May, 2011, 06.49 PM IST
- Top steelmakers in queue for mining in BellaryKarnataka government has received over 1,000 applications including from top steelmakers to mine for iron ore in the one of the state's lar...03 Dec, 2010, 06.50 AM IST
- Aurobindo Q1 net dips 69 pc to Rs 51 crDrug maker Aurobindo Pharma said its consolidated net profit declined 69.08 per cent to Rs 51.50 crore for the first quarter ended June 30,...05 Aug, 2010, 06.02 PM IST
- Aurobindo hopes to become $2 bn company in 3 yrsAurobindo Pharma hopes to become a $2-billion company in the next three years, aided by improved sales from its API business and increase i...23 Nov, 2009, 12.04 PM IST
Load More
